Affinity Depletion of Plasma and Serum for Mass Spectrometry-Based Proteome Analysis
Protein biomarker discovery in blood plasma and serum is severely hampered by the vast dynamic range of the proteome. With protein concentrations spanning 12 orders of magnitude, conventional mass spectrometric analysis allows for detection of only a few low-abundance proteins. Prior depletion of high-abundant proteins from the sample can increase analytical depth considerably and has become a widely used practice. We describe in detail an affinity depletion method that selectively removes 14 of the most abundant proteins in plasma and serum.
Key wordsPlasma Serum Depletion High abundant Analytical depth Removal Biomarker Mass spectrometry CSF Cerebrospinal fluid Agilent Sigma
This work was supported by the Stanley Medical Research Institute (SMRI, USA), Psynova Neurotech (UK), and European Union FP7 SchizDX research program (grant reference 223427).
JAJJ and DMS declare no conflict of interest. PCG and SB are consultants for Myriad-RBM although this does interfere with Springer Science policies with regards to sharing of data or materials.
- 3.Burtis CA, Ashwood ER (2001) Tietz fundamentals of clinical chemistry, 5th edn. Saunders Company, Philadelphia, PAGoogle Scholar
- 4.Wrotnowski C (1998) The future of plasma proteins. Gen Eng News 18:14Google Scholar
- 16.Fratantoni SA, Piersma SR, Jimenez CR (2010) Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting. Proteomics Clin Appl 4:613–617PubMedCrossRefGoogle Scholar
- 18.Zuberovic A, Hanrieder J, Hellman U, Bergquist J, Wetterhall M (2008) Proteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples. Eur J Mass Spectrom 14:249–260CrossRefGoogle Scholar